Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-β1 (TGF-β1) and TGF-β1–Type II Receptor Signaling Within the Aged Arterial Wall
- 1 July 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (7), 1503-1509
- https://doi.org/10.1161/01.atv.0000225777.58488.f2
Abstract
Objective— To study matrix metalloproteinase 2 (MMP-2) effects on transforming growth factor-β1 (TGF-β1) activation status and downstream signaling during arterial aging. Methods and Results— Western blotting and immunostaining showed that latent and activated TGF-β1 are markedly increased within the aorta of aged Fisher 344 cross-bred Brown Norway (30 months of age) rats compared with adult (8 months of age) rats. Aortic TGF-β1–type II receptor (TβRII), its downstream molecules p-similar to mad-mother against decapentaplegic (SMAD)2/3 and SMAD4, fibronectin, and collagen also increased with age. Moreover, TGF-β1 staining is colocalized with that of activated MMP-2 within the aged arterial wall and vascular smooth muscle cell (VSMC) in vitro, and this physical association was confirmed by coimmunoprecipitation. Incubation of young aortic rings ex vivo or VSMCs in vitro with activated MMP-2 enhanced active TGF-β1, collagen, and fibronectin expression to the level of untreated old counterparts, and this effect was abolished via inhibitors of MMP-2. Interestingly, in old untreated rings or VSMCs, the increased TGF-β1, fibronectin, and collagen were also substantially reduced by inhibition of MMP-2. Conclusions— Active TGF-β1, its receptor, and receptor-mediated signaling increase within the aortic wall with aging. TGF-β1 activation is dependent, in part at least, by a concomitant age-associated increase in MMP-2 activity. Thus, MMP-2–activated TGF-β1, and subsequently TβRII signaling, is a novel molecular mechanism for arterial aging.Keywords
This publication has 20 references indexed in Scilit:
- Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young RatsThe American Journal of Pathology, 2005
- Transforming Growth Factor-β Is Activated by Plasmin and Inhibits Smooth Muscle Cell Death in Human Saphenous VeinJournal of Vascular Research, 2005
- Rat Aortic MCP-1 and Its Receptor CCR2 Increase With Age and Alter Vascular Smooth Muscle Cell FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- TGF‐β signaling and the fibrotic responseThe FASEB Journal, 2004
- Aging Increases Aortic MMP-2 Activity and Angiotensin II in Nonhuman PrimatesHypertension, 2003
- Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease EnterprisesCirculation, 2003
- Matrix Metalloproteinase-dependent Activation of Latent Transforming Growth Factor-β Controls the Conversion of Osteoblasts into Osteocytes by Blocking Osteoblast ApoptosisJournal of Biological Chemistry, 2002
- Latent TGF‐β binding protein‐3 (LTBP‐3) requires binding to TGF‐β for secretionFEBS Letters, 2002
- Subcellular localization of (latent) transforming growth factor β and the latent TGF-β binding protein in rat hepatocytes and hepatic stellate cellsHepatology, 1998
- Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veinsGene Therapy, 1998